# Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

> **NCT05416554** · NA · NOT_YET_RECRUITING · sponsor: **Stanford University** · enrollment: 20 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **BEHAVIORAL:** Neuropsychological testing

## Key facts

- **NCT ID:** NCT05416554
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416554, "Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05416554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*